Valuation: Kenvue Inc.

Market Cap 37.13B 31.87B 29.91B 27.32B 51.56B 3,541B 51.81B 354B 137B 1,787B 139B 136B 5,917B P/E 2026 *
20.3x
P/E 2027 * 17.6x
Enterprise Value 44.23B 37.96B 35.63B 32.54B 61.41B 4,218B 61.71B 422B 163B 2,128B 166B 162B 7,048B EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.73x
Free-Float
98.88%
Yield 2026 *
4.37%
Yield 2027 * 4.46%
1 day-0.44%
1 week+0.81%
Current month+0.23%
1 month-1.00%
3 months+10.26%
6 months+1.50%
Current year+11.80%
1 week 18.87
Extreme 18.87
19.56
1 month 18.65
Extreme 18.65
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.95
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%+0.81%-7.24%-16.04% 37.13B
-0.22%+0.48%-6.98%-5.66% 338B
+0.22%+2.88%-7.67%+4.45% 140B
+0.80%+1.46%+9.57%+25.20% 72.81B
-0.16%+0.01%-24.94%-20.92% 49.89B
+0.16%+7.00%+16.76%-32.94% 37.93B
-0.58%+3.16%+8.06%+29.22% 20.53B
+0.14%+3.65%+10.80%+9.89% 20.09B
-0.69%-0.77%-26.68%-10.24% 9.97B
-0.72%-1.89%-24.92%-29.22% 7.35B
Average -0.12%+3.64%-5.32%-4.63% 73.35B
Weighted average by Cap. +0.02%+2.91%-5.02%-2.54%

Financials

2026 *2027 *
Net sales 15.6B 13.39B 12.56B 11.47B 21.66B 1,487B 21.76B 149B 57.62B 750B 58.56B 57.28B 2,485B 15.97B 13.7B 12.86B 11.75B 22.17B 1,523B 22.28B 152B 58.99B 768B 59.95B 58.65B 2,545B
Net income 1.83B 1.57B 1.47B 1.35B 2.54B 175B 2.55B 17.45B 6.76B 88.05B 6.87B 6.72B 292B 2.11B 1.81B 1.7B 1.55B 2.93B 201B 2.95B 20.14B 7.81B 102B 7.93B 7.76B 337B
Net Debt 7.1B 6.09B 5.72B 5.22B 9.85B 677B 9.9B 67.66B 26.22B 341B 26.65B 26.07B 1,131B 6.52B 5.6B 5.25B 4.8B 9.05B 622B 9.1B 62.16B 24.09B 314B 24.48B 23.95B 1,039B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-26 US$19.29 -0.23% 16,011,315
26-08-25 US$19.33 -0.51% 20,421,152
26-08-24 US$19.43 +1.94% 16,103,010
26-08-21 US$19.06 +0.69% 13,572,635
26-08-20 US$18.93 -1.05% 17,706,411
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.33USD
Average target price
19.50USD
Spread / Average Target
+0.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock